Literature DB >> 30903368

Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors.

Amy Y Zhang1, Stephen Ganocy2, Alex Z Fu3, Denise Kresevic4, Lee Ponsky5, Gerald Strauss4, Donald R Bodner4,5, Hui Zhu4.   

Abstract

PURPOSE: This study aimed to assess whether prostate cancer survivors who received a behavioral intervention to urinary incontinence had experienced a significant mood improvement.
METHODS: One hundred fifty-three prostate cancer survivors with persistent incontinence were included in this secondary data analysis. They were randomly assigned to usual care or interventions that provided pelvic floor muscle exercises and self-management skills. All subjects had measures of anxiety, depression, and anger at baseline, 3 months (post-intervention), and 6 months (follow-up). Negative binomial regression analysis was performed to examine the group status, daily leakage frequency at 3 months, and their interactions at 3 months as predictors for mood outcomes at 6 months, controlling for demographic and medical variables.
RESULTS: The main effect of daily leakage frequency at 3 months significantly predicted anxiety at 6 months (p < .01). The group main effect on any mood outcomes at 6 months was not statistically significant. The interaction between the group and 3-month leakage had a significant effect on anxiety; intervention subjects achieving a significant leakage reduction at 3 months exhibited significantly less anxiety at 6 months than other subjects (p = .04). Age, employment status, and receiving surgery at baseline were significantly associated with less anxiety, depression, and anger at 6 months.
CONCLUSIONS: Reduced urinary incontinence significantly predicted less anxiety, especially among the intervention subjects. The findings suggest a significant association between a behavioral therapy of urinary incontinence and anxiety reduction in prostate cancer survivors.

Entities:  

Keywords:  Anxiety; Behavioral intervention; Cancer care; Prostate cancer; Psychosocial studies

Mesh:

Year:  2019        PMID: 30903368     DOI: 10.1007/s00520-019-04745-w

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  36 in total

1.  Mental health outcomes in elderly men with prostate cancer.

Authors:  Praful Ravi; Pierre I Karakiewicz; Florian Roghmann; Giorgio Gandaglia; Toni K Choueiri; Mani Menon; Rana R McKay; Paul L Nguyen; Jesse D Sammon; Shyam Sukumar; Briony Varda; Steven L Chang; Adam S Kibel; Maxine Sun; Quoc-Dien Trinh
Journal:  Urol Oncol       Date:  2014-08-19       Impact factor: 3.498

2.  Prostate cancer: an intimate view from patients and wives.

Authors:  E N Heyman; T T Rosner
Journal:  Urol Nurs       Date:  1996-06

3.  Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.

Authors:  Robert T Dess; William C Jackson; Simeng Suy; Payal D Soni; Jae Y Lee; Ahmed E Abugharib; Zachary S Zumsteg; Felix Y Feng; Daniel A Hamstra; Sean P Collins; Daniel E Spratt
Journal:  Cancer       Date:  2016-12-21       Impact factor: 6.860

4.  Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.

Authors:  Valentin H Meissner; Kathleen Herkommer; Birgitt Marten-Mittag; Jürgen E Gschwend; Andreas Dinkel
Journal:  J Cancer Surviv       Date:  2017-05-21       Impact factor: 4.442

5.  Scoring the short form ICSmaleSF questionnaire. International Continence Society.

Authors:  J L Donovan; T J Peters; P Abrams; S T Brookes; J J de aa Rosette; W Schäfer
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

6.  Emotion regulation and emotional distress: The mediating role of hope on reappraisal and anxiety/depression in newly diagnosed cancer patients.

Authors:  Chao Xu Peh; Jianlin Liu; George D Bishop; Hui Yu Chan; Shi Min Chua; Ee Heok Kua; Rathi Mahendran
Journal:  Psychooncology       Date:  2016-10-24       Impact factor: 3.894

7.  Effects of Patient Centered Interventions on Persistent Urinary Incontinence after Prostate Cancer Treatment: A Randomized, Controlled Trial.

Authors:  Amy Y Zhang; Donald R Bodner; Alex Z Fu; Douglas D Gunzler; Eric Klein; Denise Kresevic; Shirley Moore; Lee Ponsky; Michael Purdum; Gerald Strauss; Hui Zhu
Journal:  J Urol       Date:  2015-07-29       Impact factor: 7.450

8.  Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.

Authors:  A J Lim; A H Brandon; J Fiedler; A L Brickman; C I Boyer; W A Raub; M S Soloway
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

9.  Psychological distress and adjustment to disease in patients before and after radical prostatectomy. Results of a prospective multi-centre study.

Authors:  N Köhler; M Friedrich; L Gansera; S Holze; R Thiel; S Roth; U Rebmann; J-U Stolzenburg; M C Truss; D Fahlenkamp; H-J Scholz; E Brähler
Journal:  Eur J Cancer Care (Engl)       Date:  2014-02-13       Impact factor: 2.520

10.  Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.

Authors:  Athene Lane; Chris Metcalfe; Grace J Young; Tim J Peters; Jane Blazeby; Kerry N L Avery; Daniel Dedman; Liz Down; Malcolm D Mason; David E Neal; Freddie C Hamdy; Jenny L Donovan
Journal:  BJU Int       Date:  2016-08-17       Impact factor: 5.588

View more
  2 in total

1.  The effectiveness of psychological intervention for depression, anxiety, and distress in prostate cancer: a systematic review of literature.

Authors:  Rhea Mundle; Evans Afenya; Neeraj Agarwal
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-03-09       Impact factor: 5.554

2.  Psychological nursing intervention on anxiety and depression in patients with urinary incontinence after radical prostatectomy: A randomized controlled study protocol.

Authors:  Liying Yang; Danjuan Ling; Lanfen Ye; Manping Zeng
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.